BioNTech SE

Stocks

BNTX

US09075V1026

Real-time Estimate Cboe BZX 14:35:54 2026-10-02 EDT			5-day change	1st Jan Change
96.48 ^USD	-0.39%		-1.88%	+1.54%

09-11	Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing	MT
09-10	European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading	MT

Transcript : BioNTech SE, InstaDeep Ltd - Special Call

Published on 10/01/2025 at 12:36 pm EDT - Modified on 11/13/2025 at 04:50 pm EST

S&P Capital IQ

Presenter Speech
Douglas Maffei (Executives)

Hi. Good afternoon, everybody. So welcome to all of you in London in the beautiful venue of the Science Museum, and to everyone joining us by webcast to our

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about BioNTech SE

09-11	Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing	MT
09-10	European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading	MT
09-08	Biontech Insider Sold Shares Worth $7,889,055, According to a Recent SEC Filing	MT
09-08	European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	MT
09-08	BMO Capital Downgrades BioNTech to Market Perform From Outperform, Adjusts PT to $105 From $128	MT
09-04	European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading	MT
09-04	BioNTech SE : Goldman Sachs gives a Buy rating	ZD
09-01	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
08-28	Health Care Down, But not by Much, on Rotation Out of Rate-Sensitive Areas - Health Care Roundup	DJ
08-28	BioNTech SE And Genentech Terminate Phase 2 Clinical Trial Collaboration For Autogene Cevumeran In Resected Colorectal Cancer	CI
08-28	Sector Update: Healthcare Stocks Decline Late Afternoon	MT
08-28	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall	MT
08-28	Upbeat Economic Outlook Buoys Swiss Market Index	MT
08-28	Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial	MT
08-28	Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal	MT